Duplications and defects in the CYP2A6 gene: identification, genotyping, and in vivo effects on smoking.
about
Phenobarbital increases monkey in vivo nicotine disposition and induces liver and brain CYP2B6 proteinPharmGKB summary: very important pharmacogene information for cytochrome P-450, family 2, subfamily A, polypeptide 6Segmental duplications and copy-number variation in the human genome.Strain-dependent effects of acute, chronic, and withdrawal from chronic nicotine on fear conditioning.Developmental effects of acute, chronic, and withdrawal from chronic nicotine on fear conditioning.Human genes involved in copy number variation: mechanisms of origin, functional effects and implications for disease.Genetic and environmental influences on the ratio of 3'hydroxycotinine to cotinine in plasma and urineDesign, baseline characteristics, and retention of African American light smokers into a randomized trial involving biological data.Precision Medicine for Tobacco Dependence: Development and Validation of the Nicotine Metabolite RatioHigh CYP2A6 enzyme activity as measured by a caffeine test and unique distribution of CYP2A6 variant alleles in Ethiopian population.The genetics of nicotine dependence: relationship to pancreatic cancer.Co-morbidity of smoking in patients with psychiatric and substance use disorders.'Smoking genes': a genetic association study.Identification of novel CYP2A6*1B variants: the CYP2A6*1B allele is associated with faster in vivo nicotine metabolism.Carbamazepine but not valproate induces CYP2A6 activity in smokers with mental illness.Candidate gene case-control association studies: advantages and potential pitfalls.Associations of CYP2A6 genotype with smoking behaviors in southern China.Copy number variants in pharmacogenetic genes.Association of CYP2A6 deletion polymorphism with smoking habit and development of pulmonary emphysema.Genetically decreased CYP2A6 and the risk of tobacco dependence: a prospective study of novice smokers.Integrating genetic studies of nicotine addiction into public health practice: stakeholder views on challenges, barriers and opportunitiesUse of the nicotine metabolite ratio as a genetically informed biomarker of response to nicotine patch or varenicline for smoking cessation: a randomised, double-blind placebo-controlled trial.A genome-wide association study of COPD identifies a susceptibility locus on chromosome 19q13.Rapid nicotine clearance is associated with greater reward and heart rate increases from intravenous nicotineCYP2A6 and CYP2B6 genetic variation and its association with nicotine metabolism in South Western Alaska Native peoplePositive and negative effects of alcohol and nicotine and their interactions: a mechanistic review.Tobacco addiction.Inactivation of CYP2A6 by the Dietary Phenylpropanoid trans-Cinnamic Aldehyde (Cinnamaldehyde) and Estimation of Interactions with Nicotine and Letrozole.Nicotine intake and smoking topography in smokers with bipolar disorderSimultaneous measurement of urinary total nicotine and cotinine as biomarkers of active and passive smoking among Japanese individualsAssociation of nicotine metabolite ratio and CYP2A6 genotype with smoking cessation treatment in African-American light smokersGenetics of tobacco use.Nicotine dependence pharmacogenetics: role of genetic variation in nicotine-metabolizing enzymesCompleting the map of human genetic variation.Applications of CYP-450 expression for biomonitoring in environmental healthA link between adolescent nicotine metabolism and smoking topography.Gene amplification and microsatellite polymorphism underlie a recent insect host shift.Pharmacogenetics of smoking cessation: role of nicotine target and metabolism genes.Parasite-host interaction in malaria: genetic clues and copy number variation.EFFECT OF CYP2A6*4 GENETIC POLYMORPHISMS ON SMOKING BEHAVIORS AND NICOTINE DEPENDENCE IN A GENERAL POPULATION OF JAPANESE MEN.
P2860
Q24671717-89A2AA24-0219-43E4-A3BE-7E2EFCD0FACDQ27012807-E8320A82-0276-49C3-8964-3F50D7CE7770Q28253048-08C37664-44EA-4EAB-B805-2A81546F432DQ30448530-B8ED2B3B-CEE2-4F75-9472-20429845E2FFQ30455063-ABAD10E6-8801-4215-A304-31FF24C8934EQ30479569-6CC8E672-EFAE-43F1-B149-68A193D04D56Q33768433-BB326548-D178-421B-AD55-17928CC81BBEQ33803436-6BAEB626-5035-446D-930F-26E14AFCFBE3Q33821233-0007CDC0-B609-470E-88FC-017C47625FA7Q33861268-B0BE01DD-D720-4E02-90B9-326BF44F4B13Q33866866-6B7D2887-7D9C-47E1-94AC-DEA7B125323AQ33942653-6CDFD054-FADD-498C-9DC1-37F8433145DFQ34064582-1CF38837-696A-4856-929E-C31E2D1B14DAQ34067100-8060A437-4CBE-4B51-86F3-D1F37DDCFDACQ34185669-6D9DBD11-1695-4EED-AC52-819023459521Q34459045-9D843AAD-2ADA-4B2D-A163-098F6378F619Q34778875-520CD2F8-64F1-48C6-80C1-D5BAFA341500Q34975631-1A535A8E-B513-4FD2-8CFA-B27CF094A15AQ35536013-764967F9-F62F-479E-8A9A-09F47E8D2ED2Q35539136-69EC2CBE-D74B-4AEA-BB66-BD864B0C33E0Q35576352-43734588-C131-422D-BA28-2388098770DAQ35782141-18237485-4354-4085-B374-A1318D6E12CDQ35816887-B5D4294F-CA6D-476A-8BC2-EF2DE69C0CEFQ35892758-17ABB6A8-6F46-412E-8DB9-B4018E630E40Q35949266-8F0F74BA-AEB5-49D4-A770-707F5A9518BCQ36039402-EF4417D2-9CB5-48D8-9A1C-723280DFA466Q36519493-A5355BD8-2CA3-42DE-988E-DE760C980277Q36737024-81E735C4-752F-4C5F-9D87-3C9BF1801CEAQ36810188-A7050F3B-9103-4004-9C1B-CD05D87A6457Q36832067-5B122233-3E5F-429B-A867-C70BED13A5A4Q36974499-6992A8CB-0FE3-4B76-BE74-48BF0063A147Q37164984-5D361AC9-927D-43CF-B9ED-61CEF5EBCF29Q37169244-7F71BF09-1F0D-46D1-85FC-E05B9397DD24Q37200545-F93CA66F-0F79-40C5-B150-7207A8C6A132Q37232322-D0F843F2-3135-446C-97A6-5C038CD2C81CQ37288535-D48E011A-F13B-4FD4-83B5-9CADBD69408AQ37353068-1CDCD78F-25AE-4D33-A105-C899257869AFQ37395740-4807D700-7EC6-4ADE-85D3-589BB2F38665Q37402635-B24A1393-1AA7-4B9A-842F-CF0E1FFF1C80Q37460963-C5363F96-5F34-4DE3-97F3-EDBD3D7E7A62
P2860
Duplications and defects in the CYP2A6 gene: identification, genotyping, and in vivo effects on smoking.
description
2000 nî lūn-bûn
@nan
2000 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Duplications and defects in th ...... nd in vivo effects on smoking.
@ast
Duplications and defects in th ...... nd in vivo effects on smoking.
@en
type
label
Duplications and defects in th ...... nd in vivo effects on smoking.
@ast
Duplications and defects in th ...... nd in vivo effects on smoking.
@en
prefLabel
Duplications and defects in th ...... nd in vivo effects on smoking.
@ast
Duplications and defects in th ...... nd in vivo effects on smoking.
@en
P2093
P1476
Duplications and defects in th ...... nd in vivo effects on smoking.
@en
P2093
E Hoffmann
E M Sellers
R F Tyndale
P304
P577
2000-10-01T00:00:00Z